-
1
-
-
77954628637
-
The prevalence of equine Cushing's syndrome in aged horses [abstract]
-
McGowan TW, Hodgson DR, McGowan CM. The prevalence of equine Cushing's syndrome in aged horses [abstract]. J Vet Intern Med 2007;21:603.
-
(2007)
J Vet Intern Med
, vol.21
, pp. 603
-
-
McGowan, T.W.1
Hodgson, D.R.2
McGowan, C.M.3
-
2
-
-
33748372929
-
Evaluation of the combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test for detection of pars intermedia adenoma in horses
-
Frank N, Andrews FM, Sommardahl CS, et al. Evaluation of the combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test for detection of pars intermedia adenoma in horses. J Vet Intern Med 2006;20:987-993.
-
(2006)
J Vet Intern Med
, vol.20
, pp. 987-993
-
-
Frank, N.1
Andrews, F.M.2
Sommardahl, C.S.3
-
3
-
-
2542618812
-
Pituitary pars intermedia dysfunction: Equine Cushing's disease
-
Schott HC. Pituitary pars intermedia dysfunction: equine Cushing's disease. Vet Clin North Am Equine Pract 2002;18:237-270.
-
(2002)
Vet Clin North Am Equine Pract
, vol.18
, pp. 237-270
-
-
Schott, H.C.1
-
4
-
-
72649091854
-
Endocrine and metabolic diseases
-
In: Smith BP, ed., 4th ed. St. Louis: Mosby
-
McFarlane D. Endocrine and metabolic diseases. In: Smith BP, ed. Large Animal Internal Medicine. 4th ed. St. Louis: Mosby; 2008:1339-1344.
-
(2008)
Large Animal Internal Medicine
, pp. 1339-1344
-
-
McFarlane, D.1
-
5
-
-
1542357574
-
The pharmacokinetics of pergolide in Parkinson's disease
-
Blin O. The pharmacokinetics of pergolide in Parkinson's disease. Curr Opin Neurol 2003;16:S9-S12.
-
(2003)
Curr Opin Neurol
, vol.16
-
-
Blin, O.1
-
6
-
-
21544431868
-
Multipledose pharmacokinetics in patients with mild to moderate Parkinson's disease
-
Thalamas C, Rjman I, Kulisevsky J, et al. Multipledose pharmacokinetics in patients with mild to moderate Parkinson's disease. Clin Neuropharmacol 2005;28:120-125.
-
(2005)
Clin Neuropharmacol
, vol.28
, pp. 120-125
-
-
Thalamas, C.1
Rjman, I.2
Kulisevsky, J.3
-
7
-
-
2542551658
-
Low-dose pergolide mesylate treatment for equine hypophyseal adenomas (Cushing's syndrome)
-
Peters DF, Erfle JB, Slobojan GT. Low-dose pergolide mesylate treatment for equine hypophyseal adenomas (Cushing's syndrome). Proc 41st Annu Meet AAEP 1995:154-155.
-
(1995)
Proc 41st Annu Meet AAEP
, pp. 154-155
-
-
Peters, D.F.1
Erfle, J.B.2
Slobojan, G.T.3
-
8
-
-
0036835141
-
Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease)
-
Donaldson MT, LaMonte BH, Morresey P, et al. Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease). J Vet Intern Med 2002;16:742-746.
-
(2002)
J Vet Intern Med
, vol.16
, pp. 742-746
-
-
Donaldson, M.T.1
Lamonte, B.H.2
Morresey, P.3
-
9
-
-
0020119947
-
Equine Cushing's disease: Plasma immunoreactive proopiomelanocortin peptide and cortisol levels basally and in response to diagnostic tests
-
Orth DN, Holscher MA, Wilson MG, et al. Equine Cushing's disease: plasma immunoreactive proopiomelanocortin peptide and cortisol levels basally and in response to diagnostic tests. Endocrinology 1982; 110:1430-1441.
-
(1982)
Endocrinology
, vol.110
, pp. 1430-1441
-
-
Orth, D.N.1
Holscher, M.A.2
Wilson, M.G.3
-
10
-
-
0041698335
-
High sensitivity quantitation of cabergoline and pergolide using triple quadrupole mass spectrometer with enhanced mass resolution capabilities
-
Hughes N, Winnik W, Dunyach J, et al. High sensitivity quantitation of cabergoline and pergolide using triple quadrupole mass spectrometer with enhanced mass resolution capabilities. J Mass Spectrom 2003;28: 743-752.
-
(2003)
J Mass Spectrom
, vol.28
, pp. 743-752
-
-
Hughes, N.1
Winnik, W.2
Dunyach, J.3
|